Page last updated: 2024-08-18

4-butyrolactone and Carcinoma, Ductal, Breast

4-butyrolactone has been researched along with Carcinoma, Ductal, Breast in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, WY; Cuyàs, E; Lupu, R; Menendez, JA; Papadimitropoulou, A; Peirce, SK; Steen, TV; Vellon, L; Verdura, S	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Carcinoma, Ductal, Breast

Article	Year
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer. Aging, 2020, 12-10, Volume: 12, Issue:24 Topics: 4-Butyrolactone; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Databases, Genetic; Fatty Acid Synthase, Type I; Humans; Interleukin-6; Prolactin; Promoter Regions, Genetic; Protein Isoforms; Receptor Cross-Talk; Receptors, Progesterone; Receptors, Prolactin; RNA, Messenger; Up-Regulation	2020

Article

Year

Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer.

Aging, 2020, 12-10, Volume: 12, Issue:24

Topics: 4-Butyrolactone; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Databases, Genetic; Fatty Acid Synthase, Type I; Humans; Interleukin-6; Prolactin; Promoter Regions, Genetic; Protein Isoforms; Receptor Cross-Talk; Receptors, Progesterone; Receptors, Prolactin; RNA, Messenger; Up-Regulation

2020